Spatial transcriptomics reveal basal sex differences in supraoptic nucleus gene expression of adult rats related to cell signaling and ribosomal pathways.
Sex differences
Spatial transcriptomics
Supraoptic nucleus
Journal
Biology of sex differences
ISSN: 2042-6410
Titre abrégé: Biol Sex Differ
Pays: England
ID NLM: 101548963
Informations de publication
Date de publication:
19 10 2023
19 10 2023
Historique:
received:
26
05
2023
accepted:
25
09
2023
medline:
23
10
2023
pubmed:
20
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
The supraoptic nucleus (SON) of the hypothalamus contains magnocellular neurosecretory cells that secrete the hormones vasopressin and oxytocin. Sex differences in SON gene expression have been relatively unexplored. Our study used spatially resolved transcriptomics to visualize gene expression profiles in the SON of adult male (n = 4) and female (n = 4) Sprague-Dawley rats using Visium Spatial Gene Expression (10x Genomics). Briefly, 10-μm coronal sections (~ 4 × 4 mm) containing the SON were collected from each rat and processed using Visium slides and recommended protocols. Data were analyzed using 10x Genomics' Space Ranger and Loupe Browser applications and other bioinformatic tools. Two unique differential expression (DE) analysis methods, Loupe Browser and DESeq2, were used. Loupe Browser DE analysis of the SON identified 116 significant differentially expressed genes (DEGs) common to both sexes (e.g., Avp and Oxt), 31 significant DEGs unique to the males, and 73 significant DEGs unique to the females. DESeq2 analysis revealed 183 significant DEGs between the two groups. Gene Ontology (GO) enrichment and pathway analyses using significant genes identified via Loupe Browser revealed GO terms and pathways related to (1) neurohypophyseal hormone activity, regulation of peptide hormone secretion, and regulation of ion transport for the significant genes common to both males and females, (2) G There was little overlap in the IPA results for the two different DE methods. These results suggest sex differences in SON gene expression that are associated with cell signaling and ribosomal pathways. The brain releases the hormones oxytocin and vasopressin from the supraoptic nucleus. Oxytocin is involved in maternal behaviors, lactation, and childbirth. Vasopressin is involved in sex-based differences in social behavior and body fluid regulation. However, how the brain contributes to sex-based differences in vasopressin and oxytocin release is poorly understood. This study aimed to address this knowledge gap using spatial transcriptomics to test for sex-based differences in gene expression in the supraoptic nucleus. Spatial transcriptomics combines anatomy with gene sequencing technology, allowing us to identify groups of genes that are expressed in specific locations in the brain. We applied this approach to brain sections containing the supraoptic nucleus from four adult male and four adult female rats. Using a data analysis workflow specifically for spatial transcriptomics, we identified genes that are significantly expressed in the supraoptic nuclei of both males and females (116 genes), primarily males (31 genes), and primarily females (73 genes). Genes enriched in the supraoptic nucleus of both males and females are related to the synthesis and release of peptides like vasopressin and oxytocin. Genes specific to the male supraoptic nucleus are broadly related to cell signaling, while the female-specific genes are related to ion transporters/channels. Results from a more traditional data analysis workflow identified sex-based differences in the expression of genes related to cell metabolism and protein synthesis. Together these results may provide a mechanistic foundation that can be used to better understand how differences in gene expression related to biological sex influence brain function.
Sections du résumé
BACKGROUND
The supraoptic nucleus (SON) of the hypothalamus contains magnocellular neurosecretory cells that secrete the hormones vasopressin and oxytocin. Sex differences in SON gene expression have been relatively unexplored. Our study used spatially resolved transcriptomics to visualize gene expression profiles in the SON of adult male (n = 4) and female (n = 4) Sprague-Dawley rats using Visium Spatial Gene Expression (10x Genomics).
METHODS
Briefly, 10-μm coronal sections (~ 4 × 4 mm) containing the SON were collected from each rat and processed using Visium slides and recommended protocols. Data were analyzed using 10x Genomics' Space Ranger and Loupe Browser applications and other bioinformatic tools. Two unique differential expression (DE) analysis methods, Loupe Browser and DESeq2, were used.
RESULTS
Loupe Browser DE analysis of the SON identified 116 significant differentially expressed genes (DEGs) common to both sexes (e.g., Avp and Oxt), 31 significant DEGs unique to the males, and 73 significant DEGs unique to the females. DESeq2 analysis revealed 183 significant DEGs between the two groups. Gene Ontology (GO) enrichment and pathway analyses using significant genes identified via Loupe Browser revealed GO terms and pathways related to (1) neurohypophyseal hormone activity, regulation of peptide hormone secretion, and regulation of ion transport for the significant genes common to both males and females, (2) G
CONCLUSION
There was little overlap in the IPA results for the two different DE methods. These results suggest sex differences in SON gene expression that are associated with cell signaling and ribosomal pathways.
The brain releases the hormones oxytocin and vasopressin from the supraoptic nucleus. Oxytocin is involved in maternal behaviors, lactation, and childbirth. Vasopressin is involved in sex-based differences in social behavior and body fluid regulation. However, how the brain contributes to sex-based differences in vasopressin and oxytocin release is poorly understood. This study aimed to address this knowledge gap using spatial transcriptomics to test for sex-based differences in gene expression in the supraoptic nucleus. Spatial transcriptomics combines anatomy with gene sequencing technology, allowing us to identify groups of genes that are expressed in specific locations in the brain. We applied this approach to brain sections containing the supraoptic nucleus from four adult male and four adult female rats. Using a data analysis workflow specifically for spatial transcriptomics, we identified genes that are significantly expressed in the supraoptic nuclei of both males and females (116 genes), primarily males (31 genes), and primarily females (73 genes). Genes enriched in the supraoptic nucleus of both males and females are related to the synthesis and release of peptides like vasopressin and oxytocin. Genes specific to the male supraoptic nucleus are broadly related to cell signaling, while the female-specific genes are related to ion transporters/channels. Results from a more traditional data analysis workflow identified sex-based differences in the expression of genes related to cell metabolism and protein synthesis. Together these results may provide a mechanistic foundation that can be used to better understand how differences in gene expression related to biological sex influence brain function.
Autres résumés
Type: plain-language-summary
(eng)
The brain releases the hormones oxytocin and vasopressin from the supraoptic nucleus. Oxytocin is involved in maternal behaviors, lactation, and childbirth. Vasopressin is involved in sex-based differences in social behavior and body fluid regulation. However, how the brain contributes to sex-based differences in vasopressin and oxytocin release is poorly understood. This study aimed to address this knowledge gap using spatial transcriptomics to test for sex-based differences in gene expression in the supraoptic nucleus. Spatial transcriptomics combines anatomy with gene sequencing technology, allowing us to identify groups of genes that are expressed in specific locations in the brain. We applied this approach to brain sections containing the supraoptic nucleus from four adult male and four adult female rats. Using a data analysis workflow specifically for spatial transcriptomics, we identified genes that are significantly expressed in the supraoptic nuclei of both males and females (116 genes), primarily males (31 genes), and primarily females (73 genes). Genes enriched in the supraoptic nucleus of both males and females are related to the synthesis and release of peptides like vasopressin and oxytocin. Genes specific to the male supraoptic nucleus are broadly related to cell signaling, while the female-specific genes are related to ion transporters/channels. Results from a more traditional data analysis workflow identified sex-based differences in the expression of genes related to cell metabolism and protein synthesis. Together these results may provide a mechanistic foundation that can be used to better understand how differences in gene expression related to biological sex influence brain function.
Identifiants
pubmed: 37858270
doi: 10.1186/s13293-023-00554-3
pii: 10.1186/s13293-023-00554-3
pmc: PMC10585758
doi:
Substances chimiques
Oxytocin
50-56-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
71Subventions
Organisme : NHLBI NIH HHS
ID : F30 HL158145
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142341
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG020494
Pays : United States
Informations de copyright
© 2023. Society for Women's Health Research and BioMed Central Ltd.
Références
J Neurosci. 2011 Sep 14;31(37):13312-22
pubmed: 21917814
Physiol Rev. 2001 Jul;81(3):1197-267
pubmed: 11427695
Mol Cell Endocrinol. 2015 Jan 15;400:102-11
pubmed: 25451978
Braz J Med Biol Res. 2013 Dec 02;46(12):1000-1006
pubmed: 24345907
Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):100-5
pubmed: 11153523
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Neuroendocrinol. 2019 Aug;31(8):e12753
pubmed: 31166034
Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):183-96
pubmed: 14769435
J Physiol. 2006 Jun 15;573(Pt 3):711-21
pubmed: 16613872
Front Physiol. 2022 May 24;13:887779
pubmed: 35685279
Elife. 2015 Nov 12;4:
pubmed: 26559902
Peptides. 1992 Jul-Aug;13(4):705-12
pubmed: 1279630
Nat Rev Neurosci. 2008 Jul;9(7):519-31
pubmed: 18509340
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nucleic Acids Res. 2016 Jul 8;44(W1):W3-W10
pubmed: 27137889
Am J Physiol Regul Integr Comp Physiol. 2015 Apr 1;308(7):R559-68
pubmed: 25632023
Neuroendocrinology. 2021;111(1-2):70-86
pubmed: 31955161
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
J Neurophysiol. 2006 May;95(5):3235-44
pubmed: 16495366
Philos Trans R Soc Lond B Biol Sci. 2022 Aug 29;377(1858):20210055
pubmed: 35858110
Endocrinology. 2011 Sep;152(9):3483-91
pubmed: 21791562
Nucleic Acids Res. 2022 Aug 26;50(15):8999
pubmed: 35904799
J Neuroendocrinol. 2012 Apr;24(4):642-52
pubmed: 22188460
Int J Mol Sci. 2021 Jul 01;22(13):
pubmed: 34281190
J Neuroendocrinol. 2012 Apr;24(4):528-38
pubmed: 21985498
Front Endocrinol (Lausanne). 2022 Dec 16;13:1056939
pubmed: 36589829
J Neuroendocrinol. 2010 May;22(5):330-42
pubmed: 20210845
Neuroendocrinology. 2021;111(3):237-248
pubmed: 32335554
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nucleic Acids Res. 2021 Jan 8;49(D1):D325-D334
pubmed: 33290552
Circ Res. 2013 Dec 6;113(12):1296-307
pubmed: 24103391
Endocr Dev. 2010;17:1-10
pubmed: 19955751
Fukuoka Igaku Zasshi. 2001 Apr;92(4):89-98
pubmed: 11411093
Endocrinology. 1999 Oct;140(10):4677-82
pubmed: 10499525
PLoS One. 2015 Apr 21;10(4):e0124523
pubmed: 25897513
Prog Neurobiol. 1995 Nov-Dec;47(4-5):291-339
pubmed: 8966209
Neuroendocrinology. 2022;112(11):1058-1077
pubmed: 35051932
Front Neurosci. 2019 Nov 20;13:1262
pubmed: 31824255
Bioinformatics. 2020 Apr 15;36(8):2628-2629
pubmed: 31882993
Peptides. 2006 May;27(5):973-9
pubmed: 16517015
Psychodyn Psychiatry. 2017 Winter;45(4):499-517
pubmed: 29244625
Neuron. 2021 Jan 20;109(2):331-346.e7
pubmed: 33212012
Mol Cell Proteomics. 2023 May;22(5):100544
pubmed: 37030596
Philos Trans R Soc Lond B Biol Sci. 2022 Aug 29;377(1858):20210059
pubmed: 35858111
Adv Exp Med Biol. 1995;395:155-71
pubmed: 8713961
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Nucleic Acids Res. 2022 Jul 5;50(W1):W345-W351
pubmed: 35446428
J Neuroendocrinol. 2019 Aug;31(8):e12752
pubmed: 31136029
Neuron. 2015 Feb 4;85(3):549-60
pubmed: 25619659
Peptides. 2004 Mar;25(3):403-11
pubmed: 15134863
PLoS One. 2015 Jun 25;10(6):e0131892
pubmed: 26110672
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Endocrinology. 2004 Nov;145(11):5141-9
pubmed: 15297447
Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021
pubmed: 31691834
Brain Behav. 2014 Jul;4(4):453-67
pubmed: 25161813
J Neurosci. 2012 Jan 11;32(2):572-82
pubmed: 22238092
J Comp Neurol. 2017 Oct 15;525(15):3360-3387
pubmed: 28685836
Cell. 2018 Feb 8;172(4):650-665
pubmed: 29425488
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1609-14
pubmed: 16432224
J Neuroendocrinol. 2021 Jun 22;33(8):e13007
pubmed: 34297454
Neuroscience. 1982 Apr;7(4):773-808
pubmed: 6124897
J Neurosci. 2007 Feb 28;27(9):2196-203
pubmed: 17329416
Adv Physiol Educ. 2002 Dec;26(1-4):225-37
pubmed: 12443995
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923